ArticleACS medicinal chemistry letters2021

Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum.

Naoki Teno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.